Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “GD2 Antibody”

28 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 28 results

Not applicableLooking for participantsNCT06574698
What this trial is testing

Adding Of Naxitamb In Induction Therapy For High Risk Neuroblastoma

Who this might be right for
NeuroblastomaGD2 Antibody (Naxitamab)
Guangzhou Women and Children's Medical Center 64
Testing effectiveness (Phase 2)Ended earlyNCT04750239
What this trial is testing

Safety and Clinical Activity of Nivatrotamab in Relapsed/Recurrent Metastatic Small-cell Lung Cancer

Who this might be right for
SCLC
Y-mAbs Therapeutics 3
Testing effectiveness (Phase 2)Study completedNCT00002458
What this trial is testing

Monoclonal Antibody Therapy in Treating Children With Metastatic Neuroblastoma in Second Remission

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT02650648
What this trial is testing

Humanized Anti-GD2 Antibody Hu3F8 and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma

Who this might be right for
NeuroblastomaHigh-Risk
Memorial Sloan Kettering Cancer Center 85
Testing effectiveness (Phase 2)Study completedNCT00445965
What this trial is testing

Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+7 more
Memorial Sloan Kettering Cancer Center 78
Not applicableLooking for participantsNCT06480526
What this trial is testing

Feasibility of Screening for Early Late Effects of Contemporary Therapy in High-Risk Neuroblastoma Survivors

Who this might be right for
High-risk Neuroblastoma
St. Jude Children's Research Hospital 45
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06948994
What this trial is testing

A Clinical Trial on Autologous NK Cells Combined With GD2 Monoclonal Antibody in the Treatment of Children With Newly Diagnosed High-risk or Relapsed/Refractory Neuroblastoma

Who this might be right for
NeuroblastomaGD2 AntibodyAutologous NK Cell
Guangzhou Women and Children's Medical Center 15
Not applicableStudy completedNCT00597272
What this trial is testing

Determine Toxicity and Antibody Responses With a KLH Conjugated Bivalent Vaccine Containing GD2 Lactone, GD3 Lactone With Immunological Adjuvant QS-DG or OPT-821 in Patients With Disease Free AJCC Stage III or IV Cutaneous Melanoma

Who this might be right for
Melanoma
Memorial Sloan Kettering Cancer Center 34
Testing effectiveness (Phase 2)Study completedNCT00089258
What this trial is testing

Biological Therapy in Treating Patients With Neuroblastoma That Has Not Responded to Previous Treatment

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center 74
Early research (Phase 1)Study completedNCT00743496
What this trial is testing

A Phase I Trial Of The Humanized Anti-GD2 Antibody In Children And Adolescents With Neuroblastoma, Osteosarcoma, Ewing Sarcoma and Melanoma

Who this might be right for
NeuroblastomaMelanomaOsteosarcoma+1 more
St. Jude Children's Research Hospital 50
Testing effectiveness (Phase 2)Ended earlyNCT03860207
What this trial is testing

Study of the Safety and Efficacy of Humanized 3F8 Bispecific Antibody (Hu3F8-BsAb) in Patients With Relapsed/Refractory Neuroblastoma, Osteosarcoma and Other Solid Tumor Cancers

Who this might be right for
NeuroblastomaOsteosarcomaOther Solid Tumor Cancers
Y-mAbs Therapeutics 12
Testing effectiveness (Phase 2)Study completedNCT00004184
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
University of Alabama at Birmingham 50
Early research (Phase 1)Study completedNCT00877110
What this trial is testing

Anti-GD2 3F8 Antibody and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma

Who this might be right for
NeuroblastomaBone Marrow, Sympathetic Nervous System
Memorial Sloan Kettering Cancer Center 71
Early research (Phase 1)Study completedNCT00003022
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+4 more
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Looking for participantsNCT06641908
What this trial is testing

Anti-GD2 ADC M3554 in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
EMD Serono Research & Development Institute, Inc. 52
Early research (Phase 1)Study completedNCT01662804
What this trial is testing

Humanized 3F8 Monoclonal Antibody (Hu3F8) When Combined With Interleukin-2 in Patients With High-Risk Neuroblastoma and GD2-positive Solid Tumors

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center 14
Early research (Phase 1)Study completedNCT00037011
What this trial is testing

Beta-Glucan and Monoclonal Antibody in Treating Patients With Metastatic Neuroblastoma

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT01857934
What this trial is testing

Therapy for Children With Advanced Stage Neuroblastoma

Who this might be right for
Neuroblastoma
St. Jude Children's Research Hospital 153
Early research (Phase 1)Study completedNCT00003023
What this trial is testing

Monoclonal Antibody A1G4 Plus BCG in Treating Patients With Cancer

Who this might be right for
NeuroblastomaSarcoma
Memorial Sloan Kettering Cancer Center 24
Early research (Phase 1)Study completedNCT00005576
What this trial is testing

Monoclonal Antibody Therapy With Sargramostim and Interleukin-2 in Treating Children With Neuroblastoma

Who this might be right for
Disseminated NeuroblastomaRecurrent NeuroblastomaRegional Neuroblastoma
National Cancer Institute (NCI) 6
Load More Results